LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 20 filers reported holding LAVA THERAPEUTICS NV in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,528,000 | -27.6% | 2,400,000 | 0.0% | 0.26% | -30.6% |
| Q2 2023 | $4,872,000 | -4.4% | 2,400,000 | -21.8% | 0.38% | +11.9% |
| Q1 2023 | $5,097,126 | -56.2% | 3,070,558 | -7.7% | 0.34% | -53.8% |
| Q4 2022 | $11,645,592 | -23.4% | 3,327,312 | 0.0% | 0.73% | +0.3% |
| Q3 2022 | $15,206,000 | +54.9% | 3,327,312 | 0.0% | 0.72% | +50.1% |
| Q2 2022 | $9,816,000 | -33.0% | 3,327,312 | 0.0% | 0.48% | -37.4% |
| Q1 2022 | $14,640,000 | -20.0% | 3,327,312 | 0.0% | 0.77% | -10.9% |
| Q4 2021 | $18,300,000 | -7.1% | 3,327,312 | 0.0% | 0.87% | -15.0% |
| Q3 2021 | $19,698,000 | -45.6% | 3,327,312 | 0.0% | 1.02% | -36.6% |
| Q2 2021 | $36,201,000 | -28.4% | 3,327,312 | 0.0% | 1.61% | -23.0% |
| Q1 2021 | $50,542,000 | – | 3,327,312 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 610,809 | $2,791,000 | 0.94% |
| Novo Holdings A/S | 3,327,312 | $15,206,000 | 0.72% |
| Redmile Group, LLC | 2,816,196 | $12,870,000 | 0.50% |
| Alpha Wave Global, LP | 121,193 | $554,000 | 0.06% |
| Artal Group S.A. | 200,000 | $914,000 | 0.04% |
| Cannell Capital | 17,955 | $82,000 | 0.02% |
| UBS OCONNOR LLC | 75,000 | $343,000,000 | 0.01% |
| AXA S.A. | 457,342 | $2,090,026 | 0.00% |
| TSFG, LLC | 400 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 48 | $0 | 0.00% |